HCPCS Level II · Coronavirus diagnostic panel and lab services
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About U0003
U0003 is an HCPCS Level II code in the U series (coronavirus diagnostic panel and lab services), describing infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r.
It was added to HCPCS effective 04/14/2020, and its current record took effect 05/12/2023.
It was terminated on 05/11/2023 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Cov-19 amp prb hgh thruput
- Date added
- 04/14/2020
- Action effective
- 05/12/2023
- Termination date
- 05/11/2023
- BETOS
- T1H
Related U00xx codes
Common questions about U0003
Is HCPCS U0003 still valid?
- No. U0003 was terminated on 05/11/2023.
Does Medicare cover U0003?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.